• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

IsoBED:一种使用调强放疗(IMRT)联合同步整合推量(SIB)技术自动计算生物等效分割方案的工具。

IsoBED: a tool for automatic calculation of biologically equivalent fractionation schedules in radiotherapy using IMRT with a simultaneous integrated boost (SIB) technique.

机构信息

Laboratory of Medical Physics and Expert System, Regina Elena Cancer Institute, Rome, Italy.

出版信息

J Exp Clin Cancer Res. 2011 May 9;30(1):52. doi: 10.1186/1756-9966-30-52.

DOI:10.1186/1756-9966-30-52
PMID:21554675
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3117739/
Abstract

BACKGROUND

An advantage of the Intensity Modulated Radiotherapy (IMRT) technique is the feasibility to deliver different therapeutic dose levels to PTVs in a single treatment session using the Simultaneous Integrated Boost (SIB) technique. The paper aims to describe an automated tool to calculate the dose to be delivered with the SIB-IMRT technique in different anatomical regions that have the same Biological Equivalent Dose (BED), i.e. IsoBED, compared to the standard fractionation.

METHODS

Based on the Linear Quadratic Model (LQM), we developed software that allows treatment schedules, biologically equivalent to standard fractionations, to be calculated. The main radiobiological parameters from literature are included in a database inside the software, which can be updated according to the clinical experience of each Institute. In particular, the BED to each target volume will be computed based on the alpha/beta ratio, total dose and the dose per fraction (generally 2 Gy for a standard fractionation). Then, after selecting the reference target, i.e. the PTV that controls the fractionation, a new total dose and dose per fraction providing the same isoBED will be calculated for each target volume.

RESULTS

The IsoBED Software developed allows: 1) the calculation of new IsoBED treatment schedules derived from standard prescriptions and based on LQM, 2) the conversion of the dose-volume histograms (DVHs) for each Target and OAR to a nominal standard dose at 2Gy per fraction in order to be shown together with the DV-constraints from literature, based on the LQM and radiobiological parameters, and 3) the calculation of Tumor Control Probability (TCP) and Normal Tissue Complication Probability (NTCP) curve versus the prescribed dose to the reference target.

摘要

背景

调强放射治疗(IMRT)技术的一个优势是可以使用同时整合boost(SIB)技术在单次治疗中向 PTV 提供不同的治疗剂量水平。本文旨在描述一种自动工具,用于计算在具有相同生物等效剂量(BED)的不同解剖区域中使用 SIB-IMRT 技术的剂量,即与标准分割相比的等剂量(IsoBED)。

方法

基于线性二次模型(LQM),我们开发了允许计算与标准分割等效的治疗计划的软件。主要的放射生物学参数来自文献中的数据库,该数据库可以根据每个机构的临床经验进行更新。特别是,将根据目标体积的α/β比值、总剂量和每次剂量(通常为标准分割的 2 Gy)来计算每个靶区的 BED。然后,在选择参考靶区(即控制分割的 PTV)后,将为每个靶区计算提供相同 IsoBED 的新总剂量和剂量。

结果

开发的 IsoBED 软件允许:1)根据 LQM 计算来自标准处方的新 IsoBED 治疗计划;2)将每个靶区和 OAR 的剂量体积直方图(DVHs)转换为名义标准剂量,即 2 Gy 每次剂量,以便与文献中的 DV 约束一起显示,基于 LQM 和放射生物学参数;3)计算参考靶区的规定剂量下的肿瘤控制概率(TCP)和正常组织并发症概率(NTCP)曲线。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/88a9/3117739/f425da66addc/1756-9966-30-52-7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/88a9/3117739/88d71f2f06e1/1756-9966-30-52-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/88a9/3117739/8d6b59f1f06b/1756-9966-30-52-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/88a9/3117739/f26831bf6c17/1756-9966-30-52-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/88a9/3117739/d5abf1ac622f/1756-9966-30-52-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/88a9/3117739/03374a26b8ca/1756-9966-30-52-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/88a9/3117739/26e13a27e57e/1756-9966-30-52-6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/88a9/3117739/f425da66addc/1756-9966-30-52-7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/88a9/3117739/88d71f2f06e1/1756-9966-30-52-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/88a9/3117739/8d6b59f1f06b/1756-9966-30-52-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/88a9/3117739/f26831bf6c17/1756-9966-30-52-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/88a9/3117739/d5abf1ac622f/1756-9966-30-52-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/88a9/3117739/03374a26b8ca/1756-9966-30-52-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/88a9/3117739/26e13a27e57e/1756-9966-30-52-6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/88a9/3117739/f425da66addc/1756-9966-30-52-7.jpg

相似文献

1
IsoBED: a tool for automatic calculation of biologically equivalent fractionation schedules in radiotherapy using IMRT with a simultaneous integrated boost (SIB) technique.IsoBED:一种使用调强放疗(IMRT)联合同步整合推量(SIB)技术自动计算生物等效分割方案的工具。
J Exp Clin Cancer Res. 2011 May 9;30(1):52. doi: 10.1186/1756-9966-30-52.
2
Simultaneous integrated intensity-modulated radiotherapy boost for locally advanced gynecological cancer: radiobiological and dosimetric considerations.同步整合调强放疗加量治疗局部晚期妇科癌症:放射生物学和剂量学考量
Int J Radiat Oncol Biol Phys. 2005 Jul 1;62(3):933-9. doi: 10.1016/j.ijrobp.2004.11.040.
3
Radiobiological considerations in the design of fractionation strategies for intensity-modulated radiation therapy of head and neck cancers.头颈部癌调强放射治疗分割策略设计中的放射生物学考量
Int J Radiat Oncol Biol Phys. 2000 Feb 1;46(3):619-30. doi: 10.1016/s0360-3016(99)00438-1.
4
Myths, facts and scope of spinal cord tolerance dose revision in Intensity modulated SIB treatment of locally advanced head and neck cancer: A dosimetrical and radiobiological demonstration.脊髓耐受剂量修订在局部晚期头颈部癌症调强同步推量照射中的误区、事实和范围:剂量学和放射生物学论证。
Cancer Radiother. 2021 Feb;25(1):8-12. doi: 10.1016/j.canrad.2020.05.015. Epub 2020 Dec 5.
5
Dosimetric comparison of standard three-dimensional conformal radiotherapy followed by intensity-modulated radiotherapy boost schedule (sequential IMRT plan) with simultaneous integrated boost-IMRT (SIB IMRT) treatment plan in patients with localized carcinoma prostate.局限性前列腺癌患者中标准三维适形放疗后序贯调强放疗推量方案(序贯调强放疗计划)与同步整合推量调强放疗(SIB IMRT)治疗计划的剂量学比较
Indian J Urol. 2012 Jul;28(3):300-6. doi: 10.4103/0970-1591.102707.
6
Radiobiological impact of dose calculation algorithms on biologically optimized IMRT lung stereotactic body radiation therapy plans.剂量计算算法对生物优化的IMRT肺部立体定向体部放射治疗计划的放射生物学影响。
Radiat Oncol. 2016 Jan 22;11:10. doi: 10.1186/s13014-015-0578-2.
7
Inverse and forward optimization of one- and two-dimensional intensity-modulated radiation therapy-based treatment of concave-shaped planning target volumes: the case of prostate cancer.基于一维和二维调强放射治疗的凹形计划靶区治疗的逆向和正向优化:以前列腺癌为例
Radiother Oncol. 2003 Feb;66(2):185-95. doi: 10.1016/s0167-8140(02)00375-4.
8
Dosimetric advantages of IMRT simultaneous integrated boost for high-risk prostate cancer.调强适形放疗同步整合加量治疗高危前列腺癌的剂量学优势
Int J Radiat Oncol Biol Phys. 2005 Mar 15;61(4):1251-7. doi: 10.1016/j.ijrobp.2004.11.034.
9
Comparative dosimetric evaluation of the simultaneous integrated boost with photon intensity modulation in head and neck cancer patients.头颈部癌患者中光子强度调制同步整合加量的剂量学比较评估
Radiother Oncol. 2003 Dec;69(3):267-75. doi: 10.1016/j.radonc.2003.10.003.
10
Critical dose and toxicity index of organs at risk in radiotherapy: analyzing the calculated effects of modified dose fractionation in non-small cell lung cancer.放射治疗中危及器官的临界剂量和毒性指数:分析非小细胞肺癌中改良剂量分割的计算效果
Med Dosim. 2014 Spring;39(1):23-30. doi: 10.1016/j.meddos.2013.08.009. Epub 2013 Nov 13.

引用本文的文献

1
Radiotherapy for HER 2 Positive Brain Metastases: Urgent Need for a Paradigm Shift.人表皮生长因子受体2阳性脑转移瘤的放射治疗:迫切需要范式转变。
Cancers (Basel). 2022 Mar 15;14(6):1514. doi: 10.3390/cancers14061514.
2
Retrospective analysis of fractionated intensity-modulated radiotherapy (IMRT) in the interdisciplinary management of primary optic nerve sheath meningiomas.原发性视神经鞘脑膜瘤多学科综合治疗中分割调强放疗的回顾性分析。
Radiat Oncol. 2019 Dec 27;14(1):240. doi: 10.1186/s13014-019-1438-2.
3
Dose-dependent atrophy of the amygdala after radiotherapy.

本文引用的文献

1
Use of normal tissue complication probability models in the clinic.正常组织并发症概率模型在临床中的应用。
Int J Radiat Oncol Biol Phys. 2010 Mar 1;76(3 Suppl):S10-9. doi: 10.1016/j.ijrobp.2009.07.1754.
2
A computational tool for the efficient analysis of dose-volume histograms from radiation therapy treatment plans.一种用于高效分析放射治疗计划中剂量-体积直方图的计算工具。
J Appl Clin Med Phys. 2010 Jan 28;11(1):3013. doi: 10.1120/jacmp.v11i1.3013.
3
A novel dose constraint to reduce xerostomia in head-and-neck cancer patients treated with intensity-modulated radiotherapy.
放疗后杏仁核的剂量依赖性萎缩。
Radiother Oncol. 2019 Jul;136:44-49. doi: 10.1016/j.radonc.2019.03.024. Epub 2019 Apr 6.
4
Boost Irradiation Integrated to Whole Brain Radiotherapy in the Management of Brain Metastases.全身放疗联合全身boost 照射治疗脑转移瘤。
Pathol Oncol Res. 2020 Jan;26(1):149-157. doi: 10.1007/s12253-018-0383-y. Epub 2018 Jan 17.
5
Regional susceptibility to dose-dependent white matter damage after brain radiotherapy.脑部放疗后白质损伤剂量依赖性的区域易感性。
Radiother Oncol. 2017 May;123(2):209-217. doi: 10.1016/j.radonc.2017.04.006. Epub 2017 May 2.
6
Cerebral Cortex Regions Selectively Vulnerable to Radiation Dose-Dependent Atrophy.大脑皮层区域对辐射剂量依赖性萎缩具有选择性易损性。
Int J Radiat Oncol Biol Phys. 2017 Apr 1;97(5):910-918. doi: 10.1016/j.ijrobp.2017.01.005. Epub 2017 Jan 6.
7
Radiation Dose-Dependent Hippocampal Atrophy Detected With Longitudinal Volumetric Magnetic Resonance Imaging.通过纵向容积磁共振成像检测到的辐射剂量依赖性海马萎缩
Int J Radiat Oncol Biol Phys. 2017 Feb 1;97(2):263-269. doi: 10.1016/j.ijrobp.2016.10.035. Epub 2016 Oct 31.
8
Dose-dependent white matter damage after brain radiotherapy.脑部放疗后剂量依赖性白质损伤。
Radiother Oncol. 2016 Nov;121(2):209-216. doi: 10.1016/j.radonc.2016.10.003. Epub 2016 Oct 21.
9
Simultaneous integrated boost with intensity modulated radiation therapy in brain oligometastases: A feasible technique for developing countries.脑寡转移瘤同步整合加量调强放射治疗:一种适用于发展中国家的可行技术。
South Asian J Cancer. 2015 Jan-Mar;4(1):11-4. doi: 10.4103/2278-330X.149927.
10
Biological effects and equivalent doses in radiotherapy: A software solution.放射治疗中的生物学效应与等效剂量:一种软件解决方案。
Rep Pract Oncol Radiother. 2013 Sep 29;19(1):47-55. doi: 10.1016/j.rpor.2013.08.004. eCollection 2014 Jan.
一种新的剂量限制方法,可减少调强放疗治疗头颈部癌症患者的口干症。
Int J Radiat Oncol Biol Phys. 2010 May 1;77(1):269-76. doi: 10.1016/j.ijrobp.2009.07.1734. Epub 2010 Jan 25.
4
Comparison of IMRT planning with two-step and one-step optimization: a strategy for improving therapeutic gain and reducing the integral dose.比较两步法和一步法优化的调强放疗计划:提高治疗增益和降低积分剂量的策略。
Phys Med Biol. 2009 Dec 7;54(23):7183-98. doi: 10.1088/0031-9155/54/23/010. Epub 2009 Nov 17.
5
Analysis of salivary flow and dose-volume modeling of complication incidence in patients with head-and-neck cancer receiving intensity-modulated radiotherapy.头颈部癌患者接受调强放疗时唾液流量分析及并发症发生率的剂量-体积建模
Int J Radiat Oncol Biol Phys. 2009 Mar 15;73(4):1252-9. doi: 10.1016/j.ijrobp.2008.11.020.
6
Hypofractionated Conformal Radiotherapy (HCRT) for primary and metastatic lung cancers with small dimension : efficacy and toxicity.小尺寸原发性和转移性肺癌的大分割适形放射治疗(HCRT):疗效与毒性
Strahlenther Onkol. 2009 Jan;185(1):27-33. doi: 10.1007/s00066-009-1873-3. Epub 2009 Feb 18.
7
Linear quadratics is alive and well: in regard to Park et al. (Int J Radiat Oncol Biol Phys 2008;70:847-852).线性二次模型依然存在且发展良好:关于帕克等人(《国际放射肿瘤学、生物学、物理学杂志》2008年;70:847 - 852)的研究。
Int J Radiat Oncol Biol Phys. 2008 Nov 1;72(3):957; author reply 958. doi: 10.1016/j.ijrobp.2008.06.1929.
8
Mathematical model for evaluating incidence of acute rectal toxicity during conventional or hypofractionated radiotherapy courses for prostate cancer.评估前列腺癌常规或大分割放疗疗程中急性直肠毒性发生率的数学模型。
Int J Radiat Oncol Biol Phys. 2009 Apr 1;73(5):1454-60. doi: 10.1016/j.ijrobp.2008.07.024. Epub 2008 Nov 5.
9
A heterogeneous dose distribution in simultaneous integrated boost: the role of the clonogenic cell density on the tumor control probability.同步整合加量中剂量分布的异质性:克隆源性细胞密度对肿瘤控制概率的作用。
Phys Med Biol. 2008 Oct 7;53(19):5257-73. doi: 10.1088/0031-9155/53/19/001. Epub 2008 Aug 29.
10
Universal survival curve and single fraction equivalent dose: useful tools in understanding potency of ablative radiotherapy.通用生存曲线和单次分割等效剂量:理解消融性放射治疗效能的有用工具。
Int J Radiat Oncol Biol Phys. 2008 Mar 1;70(3):847-52. doi: 10.1016/j.ijrobp.2007.10.059.